NMR Analysis of a Tau Phosphorylation Pattern
Authors:
- Ludovic LacosseLLLudovic Lacosse
- Arnaud LeroyALArnaud Leroy
- Jean-Michel WieruszeskiJWJean-Michel Wieruszeski
- Xavier TrivelliXTXavier Trivelli
- Alain SillenASAlain Sillen
- Nathalie SibilleNathalie Sibille
- Harald SchwalbeHSHarald Schwalbe
- Krishna SaxenaKSKrishna Saxena
- Thomas LangerTLThomas Langer
- Guy LippensGLGuy Lippens
- 1 March 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 128 (11) , 3575-3583
Abstract
The phosphorylation of the neuronal Tau protein modulates both its physiological role of microtubule binding and its aggregation into paired helical fragments observed in Alzheimer's diseased neurons. However, detailed knowledge of the role of phosphorylation at specific sites has been hampered by the analytical difficulties to evaluate the level of site-specific phosphate incorporation. Even with recombinant kinases, mass spectrometry and immunodetection are not evident for determining the full phosphorylation pattern in a qualitative and quantitative manner. We show here that heteronuclear NMR spectroscopy on a 15N labeled Tau sample modified by the cAMP dependent kinase allows identification of all phosphorylation sites, measures their level of phosphate integration, and yields kinetic data for the enzymatic modification of the individual sites. Filtering through the 15N label discards the necessity of any further sample purification and allows the in situ monitoring of kinase activity at selected sites. We finally demonstrate that the NMR approach can equally be used to evaluate potential kinase inhibitors in a straightforward manner.Keywords
This publication has 45 references indexed in Scilit:
- Phosphorylated tau and the neurodegenerative foldopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- Tau protein as a differential biomarker of tauopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- NMR Backbone Assignment of a Protein Kinase Catalytic Domain by a Combination of Several Approaches: Application to the Catalytic Subunit of cAMP‐Dependent Protein KinaseChemBioChem, 2004
- Development of an Assay to Screen for Inhibitors of Tau Phosphorylation by Cdk5SLAS Discovery, 2004
- Sequential phosphorylation of Tau by glycogen synthase kinase‐3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer‐specific epitope of antibody AT100 and requires a paired‐helical‐filament‐like conformationEuropean Journal of Biochemistry, 1998
- Phosphorylation-dependent Monoclonal Tau Antibodies Do Not Reliably Report Phosphorylation by Extracellular Signal-regulated Kinase 2 at Specific SitesJournal of Biological Chemistry, 1997
- Protein Folding Monitored at Individual Residues During a Two-Dimensional NMR ExperimentScience, 1996
- Mitotic mechanisms in Alzheimer's disease?Journal of Cell Biology, 1996
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995
- Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404Journal of Neuroscience Research, 1994